Search Results 1021-1030 of 13934 for Assay

  1. Publications - Karen S. Anderson, M.D., Ph.D. - Mayo Clinic

    ... assay for JAK2 and PD-L1 amplification. Mod Pathol. 2017 Nov; 30 (11):1516-1526 Epub 2017 July 28. View PubMed; Maley CC, Aktipis A, Graham TA, Sottoriva A ...

  2. A Study Of TNB-383B In Subjects With Relapsed Or Refractory Multiple Myeloma - Mayo Clinic

    Serum free light chain (FLC) assay: Involved FLC level ≥ 10 mg/dl (≥ 100 mg/L) and an abnormal serum FLC ratio (< 0.26 or > 1.65). Subject has an Eastern ...

  3. Kevin C. Halling, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    ... assays and how to clinically interpret the results obtained with these assays. Dr. Halling's research helps address these needs. Professional highlights.

  4. FAQ - eMERGE Genome Informed Risk Assessment - Mayo Clinic Research

    The eMERGE study focuses on polygenic risk scores, which estimate the risk of getting a disease from variants in multiple genes. The study aims to learn how ...

  5. Pemigatinib trial seeks to build on targeted advances in cholangiocarcinoma - Mayo Clinic

    The assay is a next-generation sequencing device that detects alterations in 324 genes using DNA isolated from formalin-fixed paraffin-embedded tumor tissue ...

  6. A Registry To Form A Long-Term Therapeutic And Research Network For Hepatitis C - Mayo Clinic

    Studies comparing HCV RNA assays are not considered exclusionary. Participating Mayo Clinic locations. Study statuses change often. Please contact the study ...

  7. Publications - Cathy L. Gebhart, Ph.D. - Mayo Clinic

    Implementation of a T4 extraction control for molecular assays of cerebrospinal fluid and stool specimens. J Mol Diagn. 2008 Jan; 10 (1):28-32 Epub 2007 Dec ...

  8. Stomach Cancer Clinical Trials - Mayo Clinic Research

    ... assays using patient peripheral blood immune cells or serum. cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal ...

  9. Publications - Nathanael G. Bailey, M.D. - Mayo Clinic

    Visualization of the Effect of Assay Size on the Error Profile of Tumor Mutational Burden Measurement. ... assays. Appl Immunohistochem Mol Morphol. 2015 ...

  10. SAR650984, Pomalidomide and Dexamethasone in Combination in RRMM Patients - Mayo Clinic

    Serum free light chain (FLC) assay: Involved FLC assay ≥ 10 mg/dL (≥ 100 mg/L) and an abnormal serum FLC ratio (< 0.26 or > 1.65). Females of childbearing ...